Kimberly S. Meza: PIM-Pointing a TRAIL for Cancer Cures

Kimberly Stephanie Meza, Pathobiology PhD’26, shares how her sister’s cancer diagnosis inspired her path into cancer research. She explores how targeting PIM1 kinase influences cancer cell responses to TRAIL-induced cell death, revealing a new and promising therapeutic strategy for kidney cancer.

This talk was part of Research Matters, featuring short talks about research by Brown University Graduate Students on April 27, 2026, at Brown University. For more information, please visit: https://graduateschool.brown.edu/